Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00536
|
|||||
Drug Name |
Tubocurarine
|
|||||
Synonyms |
(+)-Tubocurarine; (+)-Tubocurarine chloride; (+)-Tubocurarine chloride hydrochloride; 2,2',2'-trimethyl-6,6'-bis(methyloxy)tubocuraran-2,2'-diium-7',12'-diol dichloride; 7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium; 7',12'-dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraran-2'-ium; Amelizol; Chlorure de tubocurarine; Chlorure de tubocurarine [INN-French]; Cloruro de tubocurarina; Cloruro de tubocurarina [INN-Spanish]; Curarin-haf; D-(+)-Tubocurarine chloride; D-7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium chloride; D-Paracurarine chloride; D-Tubocurarine; D-Tubocurarine chloride; D-Tubocurarine dichloride; D-Tubocurarine hydrochloride; Delacurarine; Delacurarine (TN); Dextrotubocurarine chloride; Intocostrine T; Isoquinoline alkaloid; Jex (TN); Jexin; Metubine (TN); Tubadil; Tubaine; Tubaine (TN); Tubarine; Tubarine (TN); Tubocuraranium, 7',12'-dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyl-, chloride, hydrochloride; Tubocurarin; Tubocurarina cloruro; Tubocurarina cloruro [DCIT]; Tubocurarine chloride; Tubocurarine chloride (INN); Tubocurarine chloride (TN); Tubocurarine chloride (anhydrous); Tubocurarine hydrochloride; Tubocurarine, chloride, hydrochloride, (+)-(8CI); Tubocurarini chloridum; Tubocurarini chloridum [INN-Latin]; Tubocurarinum; Tubocurarinum (TN)
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Anesthesia [ICD11: MB40.3, MB40.8] | Approved | [1] | |||
Smoking withdrawl syndrom [ICD11: 6C4A.2] | Approved | [1] | ||||
Therapeutic Class |
Neuromuscular Nondepolarizing Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C37H41N2O6+
|
|||||
Canonical SMILES |
CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC
|
|||||
InChI |
InChI=1S/C37H40N2O6/c1-38-14-12-24-19-32(42-4)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-37-35-25(20-34(43-5)36(37)41)13-15-39(2,3)29(35)17-23-8-11-30(40)31(18-23)45-33/h6-11,18-21,28-29H,12-17H2,1-5H3,(H-,40,41)/p+1/t28-,29+/m0/s1
|
|||||
InChIKey |
JFJZZMVDLULRGK-URLMMPGGSA-O
|
|||||
CAS Number |
CAS 6989-98-6
|
|||||
Pharmaceutical Properties | Molecular Weight | 609.7 | Topological Polar Surface Area | 80.6 | ||
Heavy Atom Count | 45 | Rotatable Bond Count | 2 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | |||
XLogP |
6
|
|||||
PubChem CID | ||||||
PubChem SID |
104037209
, 104310830
, 11341746
, 11361929
, 11364928
, 11367490
, 11370052
, 11372089
, 11375402
, 11378222
, 11485225
, 11487331
, 11489151
, 11490910
, 11493736
, 11495780
, 115001452
, 115001455
, 11537649
, 124892413
, 134337662
, 134453346
, 134971353
, 135652723
, 135890516
, 136948051
, 137003129
, 142970979
, 15217798
, 160845901
, 160964532
, 164153589
, 17425509
, 175443878
, 26756599
, 29225014
, 46505279
, 47736639
, 47959927
, 47959928
, 48035288
, 50070796
, 50123130
, 53789134
, 57323106
, 598405
, 79261593
, 7979097
, 92308722
, 9750
|
|||||
ChEBI ID |
ChEBI:9774
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
References | ||||||
1 | Tubocurarine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.